Advanced search
Publication Cover
Molecular & Cellular Oncology Volume 10, 2023 - Issue 1
Submit an article Journal homepage
1,718
Views
0
CrossRef citations to date
0
Altmetric
Author’s Views

APOBEC3 as a driver of genetic intratumor heterogeneity

Subramanian Venkatesana Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK;b Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UKORCID Iconhttps://orcid.org/0000-0001-6454-8508View further author information
ORCID Icon,
Mihaela Angelovaa Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UKView further author information
,
Jirina Bartkovac Genome Integrity Unit, Danish Cancer Society Research Center, Copenhagen, Denmark;d Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Karolinska Institute, Stockholm, SwedenView further author information
,
Samuel F. Bakhoume Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA;f Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USACorrespondence[email protected]
View further author information
,
Jiri Bartekc Genome Integrity Unit, Danish Cancer Society Research Center, Copenhagen, Denmark;d Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Karolinska Institute, Stockholm, SwedenCorrespondence[email protected]
View further author information
,
Nnennaya Kanub Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UKCorrespondence[email protected]
View further author information
&
Charles Swantona Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK;b Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UK;g Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UKCorrespondence[email protected]
View further author information
 show all
Article: 2014734 | Received 03 Nov 2021, Accepted 01 Dec 2021, Published online: 03 Jan 2022

References

  • Jalili P, Bowen D, Langenbucher A, Park S, Aguirre K, Corcoran RB, Fleischman AG, Lawrence MS, Zou L, Buisson R, et al. Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots. Nat Commun. 2020;11(1):2971. doi:10.1038/s41467-020-16802-8.
  • Swanton C, McGranahan N, Starrett GJ, Harris RS. APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov. 2015;5:704–4. doi:10.1158/2159-8290.CD-15-0344.
  • Venkatesan S, Angelova M, Puttick C, Zhai H, Caswell DR, Lu W-T, Dietzen M, Galanos P, Evangelou K, Bellelli R, et al. Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution. Cancer Discov. 2021;11(10):2456–2473. doi:10.1158/2159-8290.CD-20-0725.
  • Nikkila J, Kumar R, Campbell J, Brandsma I, Pemberton HN, Wallberg F, Nagy K, Scheer I, Vertessy BG, Serebrenik AA, et al. Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells. Br J Cancer. 2017;117(1):113–123. doi:10.1038/bjc.2017.133.
  • Wang D, Li X, Li J, Lu Y, Zhao S, Tang X, Chen X, Li J, Zheng Y, Li S, et al. APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression. Gut. 2019;68(10):1846–1857. gutjnl-2018-317601. doi:10.1136/gutjnl-2018-317601.
  • Wörmann SM, Zhang A, Thege FI, Cowan RW, Rupani DN, Wang R, Manning SL, Gates C, Wu W, Levin-Klein R, et al. APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. Nat Cancer. 2021. doi:10.1038/s43018-021-00268-8.
  • Mehta KPM, Lovejoy CA, Zhao R, Heintzman DR, Cortez D. HMCES maintains replication fork progression and prevents double-strand breaks in response to APOBEC deamination and abasic site formation. Cell Rep. 2020;31:107705. doi:10.1016/j.celrep.2020.107705.
  • Jamal-Hanjani M, Wilson GA, McGranahan N, Birkbak NJ, Watkins TBK, Veeriah S, Shafi S, Johnson DH, Mitter R, Rosenthal R, et al. Tracking the evolution of non–small-cell lung cancer. N Engl J Med. 2017;376(22):2109–2121. doi:10.1056/NEJMoa1616288.
  • Driscoll CB, Schuelke MR, Kottke T, Thompson JM, Wongthida P, Tonne JM, Huff AL, Miller A, Shim KG, Molan A. APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy. Nat Commun. 2020;11(790). doi:10.1038/s41467-020-14568-7
  • Wolf Y, Bartok O, Patkar S, Eli GB, Cohen S, Litchfield K, Levy R, Jiménez-Sánchez A, Trabish S, Lee JS, et al. UVB-Induced tumor heterogeneity diminishes immune response in melanoma. Cell. 2019;179(1):219–235 e221. doi:10.1016/j.cell.2019.08.032.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.